Union Health said it would submit a new Certificate of Public Advantage application to try to acquire Terre Haute Regional Hospital.
Indiana health system withdraws merger application after regulator pushback Read More »
Twenty-three percent of working-age adults with health insurance face high out-of-pocket costs that make it difficult to afford care, according to a survey by the Commonwealth Fund.
Nearly a quarter of Americans are underinsured: report Read More »
About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration allows the rule to go into effect — at the cost of $40 billion to federal and state governments.
Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs Read More »
Martin Makary, a Johns Hopkins surgeon and researcher, has been critical of the FDA. He could have the most influence over device policy among Trump’s nominees.
Advamed CEO stresses need for safety, efficacy after Trump picks Makary to lead FDA Read More »
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
The Biggest Pharma Share Moves of the Year So Far Read More »
Un avance científico abre nuevas posibilidades para analizar restos óseos fragmentados en el registro arqueológico. Un equipo multidisciplinar ha desarrollado una nueva metodología para analizar fracturas craneales humanas del pasado. Esta investigación se …
Un nuevo estudio revela la distribución de receptores NMDA, esenciales para la memoria, en cerebros con la enfermedad de Alzheimer. La investigación se ha realizado en cerebros humanos de personas fallecidas. El estudio es obra de un equipo del Instituto de Neurociencias (IN), …
Trump is rounding out his health cabinet with another controversial figure: one of the authors of the Great Barrington Declaration, which advocated for herd immunity through infection during the COVID-19 pandemic.
Trump Picks Stanford’s Jay Bhattacharya as NIH Lead Read More »
Despite the “unfortunate” failure, William Blair analysts do not believe that the utreloxastat readout will heavily affect PTC, instead postulating that the upcoming FDA decision on its phenylketonuria candidate sepiapterin will be a stronger driver of the biotech’s stock.
PTC Scraps ALS Asset Utreloxastat After Mid-Stage Fail, Analysts Look to PKU Opportunity Read More »
Unos ingenieros están probando en una piscina prototipos de robots para futuras misiones espaciales, en las cuales enjambres de robots subacuáticos buscarán señales de vida en mares de otros mundos. Cuando la sonda espacial Europa Clipper de la NASA llegue a su d …
Hacia enjambres de robots subacuáticos para investigar mares extraterrestres Read More »
